Updates in Specialty Care

Article Type
Changed
Tue, 05/03/2022 - 16:00
Display Headline
Updates in Specialty Care

Article PDF
Author and Disclosure Information

Leonard Pogach, MD, MBA; Paul R. Conlin, MD; Curtis Hobbs, MD; Robert A. Vigersky, MD; and David Aron, MD, MS; for the VA-DoD Diabetes Guideline Working Group

Dr. Pogach is director, Health Services Research & Development (HSR&D) Center for Healthcare Knowledge Management at the VA New Jersey Health Care System in East Orange and national program director, Endocrinology and Diabetes, Office of Subspecialty Services in the VA Office of Patient Care Services in Washington, DC. Dr. Conlin is chief of medicine at the VA Boston Healthcare System in Massachusetts. Dr. Hobbs is director, Diabetes Care Center, Madigan Healthcare System at Madigan Army Medical Center in Tacoma, Washington. Dr. Vigersky is director, Diabetes Institute, Walter Reed Health Care System at Walter Reed Army Medical Center in Washington, DC. Dr. Aron is associate chief of staff/education and co-director, VA HSR&D Center for Implementation Practice and Research Support at Louis Stokes Cleveland VA Medical Center in Ohio.

Issue
Federal Practitioner - 28(4)
Publications
Topics
Page Number
39
Legacy Keywords
diabetes, clinical practice guidelines, GRADE instrument, comorbid conditions, glycemic targets, A1c tests, estimated average glucose, glucose-based tests, glycemic control, hemolytic anemia, iron deficiency anemia, severe chronic kidney disease, National Glycohemoglobin Standardization Program, coefficient of variation, mean plasma glucose, Working Group, glucose-lowering agents, Action to Control Cardiovascular Risk in Diabetes, VA Diabetes Trial, Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluationdiabetes, clinical practice guidelines, GRADE instrument, comorbid conditions, glycemic targets, A1c tests, estimated average glucose, glucose-based tests, glycemic control, hemolytic anemia, iron deficiency anemia, severe chronic kidney disease, National Glycohemoglobin Standardization Program, coefficient of variation, mean plasma glucose, Working Group, glucose-lowering agents, Action to Control Cardiovascular Risk in Diabetes, VA Diabetes Trial, Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation
Sections
Author and Disclosure Information

Leonard Pogach, MD, MBA; Paul R. Conlin, MD; Curtis Hobbs, MD; Robert A. Vigersky, MD; and David Aron, MD, MS; for the VA-DoD Diabetes Guideline Working Group

Dr. Pogach is director, Health Services Research & Development (HSR&D) Center for Healthcare Knowledge Management at the VA New Jersey Health Care System in East Orange and national program director, Endocrinology and Diabetes, Office of Subspecialty Services in the VA Office of Patient Care Services in Washington, DC. Dr. Conlin is chief of medicine at the VA Boston Healthcare System in Massachusetts. Dr. Hobbs is director, Diabetes Care Center, Madigan Healthcare System at Madigan Army Medical Center in Tacoma, Washington. Dr. Vigersky is director, Diabetes Institute, Walter Reed Health Care System at Walter Reed Army Medical Center in Washington, DC. Dr. Aron is associate chief of staff/education and co-director, VA HSR&D Center for Implementation Practice and Research Support at Louis Stokes Cleveland VA Medical Center in Ohio.

Author and Disclosure Information

Leonard Pogach, MD, MBA; Paul R. Conlin, MD; Curtis Hobbs, MD; Robert A. Vigersky, MD; and David Aron, MD, MS; for the VA-DoD Diabetes Guideline Working Group

Dr. Pogach is director, Health Services Research & Development (HSR&D) Center for Healthcare Knowledge Management at the VA New Jersey Health Care System in East Orange and national program director, Endocrinology and Diabetes, Office of Subspecialty Services in the VA Office of Patient Care Services in Washington, DC. Dr. Conlin is chief of medicine at the VA Boston Healthcare System in Massachusetts. Dr. Hobbs is director, Diabetes Care Center, Madigan Healthcare System at Madigan Army Medical Center in Tacoma, Washington. Dr. Vigersky is director, Diabetes Institute, Walter Reed Health Care System at Walter Reed Army Medical Center in Washington, DC. Dr. Aron is associate chief of staff/education and co-director, VA HSR&D Center for Implementation Practice and Research Support at Louis Stokes Cleveland VA Medical Center in Ohio.

Article PDF
Article PDF

Issue
Federal Practitioner - 28(4)
Issue
Federal Practitioner - 28(4)
Page Number
39
Page Number
39
Publications
Publications
Topics
Article Type
Display Headline
Updates in Specialty Care
Display Headline
Updates in Specialty Care
Legacy Keywords
diabetes, clinical practice guidelines, GRADE instrument, comorbid conditions, glycemic targets, A1c tests, estimated average glucose, glucose-based tests, glycemic control, hemolytic anemia, iron deficiency anemia, severe chronic kidney disease, National Glycohemoglobin Standardization Program, coefficient of variation, mean plasma glucose, Working Group, glucose-lowering agents, Action to Control Cardiovascular Risk in Diabetes, VA Diabetes Trial, Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluationdiabetes, clinical practice guidelines, GRADE instrument, comorbid conditions, glycemic targets, A1c tests, estimated average glucose, glucose-based tests, glycemic control, hemolytic anemia, iron deficiency anemia, severe chronic kidney disease, National Glycohemoglobin Standardization Program, coefficient of variation, mean plasma glucose, Working Group, glucose-lowering agents, Action to Control Cardiovascular Risk in Diabetes, VA Diabetes Trial, Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation
Legacy Keywords
diabetes, clinical practice guidelines, GRADE instrument, comorbid conditions, glycemic targets, A1c tests, estimated average glucose, glucose-based tests, glycemic control, hemolytic anemia, iron deficiency anemia, severe chronic kidney disease, National Glycohemoglobin Standardization Program, coefficient of variation, mean plasma glucose, Working Group, glucose-lowering agents, Action to Control Cardiovascular Risk in Diabetes, VA Diabetes Trial, Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluationdiabetes, clinical practice guidelines, GRADE instrument, comorbid conditions, glycemic targets, A1c tests, estimated average glucose, glucose-based tests, glycemic control, hemolytic anemia, iron deficiency anemia, severe chronic kidney disease, National Glycohemoglobin Standardization Program, coefficient of variation, mean plasma glucose, Working Group, glucose-lowering agents, Action to Control Cardiovascular Risk in Diabetes, VA Diabetes Trial, Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media